Literature DB >> 35676548

CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.

Xiaoqin Li1, Xuemei Jiang1, Jing Lu2, Yuting Lin1, Lan Jiang1, Yan Li1, Feng Wan1, Changmin Wang3.   

Abstract

Accumulating evidence have demonstrated that circular RNAs (circRNAs) exert important roles in tumor initiation and progression. Nevertheless, the role and mechanism of circRNA ceramide synthase 6 (circCERS6) in epithelial ovarian cancer (EOC) remain to be clarified. Using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay, we measured RNA and protein expression. We analyzed the effects of circCERS6/microRNA-630 (miR-630)/Ras-association domain family member 8 (RASSF8) axis in cell proliferation, migration, and invasion by 5-Ethynyl-2'-deoxyuridine (EdU) assay, colony formation assay, scratch test, and transwell assay. Using RNA-pull down assay and dual-luciferase reporter assay, the interaction between miR-630 and circCERS6 or RASSF8 was verified. The in vivo role of circCERS6 in tumor growth was analyzed using xenograft mice model. CircCERS6 expression was markedly reduced in EOC tissues and cell lines. CircCERS6 overexpression hampered the proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of EOC cells. CircCERS6 directly interacted with miR-630. miR-630 expression was up-regulated in EOC tissues and cell lines. CircCERS6 overexpression-induced anti-tumor effects in EOC were largely reversed by the overexpression of miR-630. RASSF8 was a direct target of miR-630. RASSF8 level was decreased in EOC tissues and cell lines. CircCERS6 up-regulated RASSF8 expression by acting as a molecular sponge for miR-630 in EOC cells. CircCERS6 overexpression-mediated suppressive effects in EOC cells were largely overturned by the silence of RASSF8. CircCERS6 overexpression blocked tumor growth in vivo. CircCERS6 overexpression hampered the proliferation, migration, invasion, and EMT of EOC cells by up-regulating RASSF8 via sponging miR-630.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Epithelial ovarian cancer; RASSF8; circCERS6; miR-630

Year:  2022        PMID: 35676548     DOI: 10.1007/s10528-022-10227-2

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  30 in total

Review 1.  Regulation of mRNA translation and stability by microRNAs.

Authors:  Marc Robert Fabian; Nahum Sonenberg; Witold Filipowicz
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  Circular RNA profiling reveals circRNA1656 as a novel biomarker in high grade serous ovarian cancer.

Authors:  Yan Gao; Chuanqi Zhang; Yisi Liu; Min Wang
Journal:  Biosci Trends       Date:  2019-04-24       Impact factor: 2.400

Review 3.  Rassf family of tumor suppressor polypeptides.

Authors:  Joseph Avruch; Ramnik Xavier; Nabeel Bardeesy; Xian-Feng Zhang; Maria Praskova; Dawang Zhou; Fan Xia
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

4.  MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.

Authors:  Kyung Jin Eoh; So Hyun Lee; Hee Jung Kim; Jung-Yun Lee; Sunghoon Kim; Sang Wun Kim; Young Tae Kim; Eun Ji Nam
Journal:  Biochem Biophys Res Commun       Date:  2018-02-13       Impact factor: 3.575

Review 5.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.

Authors:  David D Bowtell; Steffen Böhm; Ahmed A Ahmed; Paul-Joseph Aspuria; Robert C Bast; Valerie Beral; Jonathan S Berek; Michael J Birrer; Sarah Blagden; Michael A Bookman; James D Brenton; Katherine B Chiappinelli; Filipe Correia Martins; George Coukos; Ronny Drapkin; Richard Edmondson; Christina Fotopoulou; Hani Gabra; Jérôme Galon; Charlie Gourley; Valerie Heong; David G Huntsman; Marcin Iwanicki; Beth Y Karlan; Allyson Kaye; Ernst Lengyel; Douglas A Levine; Karen H Lu; Iain A McNeish; Usha Menon; Steven A Narod; Brad H Nelson; Kenneth P Nephew; Paul Pharoah; Daniel J Powell; Pilar Ramos; Iris L Romero; Clare L Scott; Anil K Sood; Euan A Stronach; Frances R Balkwill
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

6.  Low programmed cell death 5 expression is a prognostic factor in ovarian cancer.

Authors:  Li Gao; Xue Ye; Rui-Qiong Ma; Hong-Yan Cheng; Hong-Jing Han; Heng Cui; Li-Hui Wei; Xiao-Hong Chang
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

7.  Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.

Authors:  Chuan He; Libo Wang; Jiantao Zhang; Hong Xu
Journal:  Mol Cancer       Date:  2017-02-07       Impact factor: 27.401

Review 8.  Circular RNAs in cancer: opportunities and challenges in the field.

Authors:  L S Kristensen; T B Hansen; M T Venø; J Kjems
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

9.  Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis.

Authors:  Junming Bi; Hongwei Liu; Zijian Cai; Wei Dong; Ning Jiang; Meihua Yang; Jian Huang; Tianxin Lin
Journal:  Aging (Albany NY)       Date:  2018-08-09       Impact factor: 5.682

10.  CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a.

Authors:  Xiaoling Gan; Hongtao Zhu; Xingwei Jiang; Samuel C Obiegbusi; Min Yong; Xingtao Long; Jianguo Hu
Journal:  Mol Cancer       Date:  2020-02-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.